QA: Nascent Biotech Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001622057_2023_Nascent_Biotech_Inc.pdf

Logs

Graph

Absolute values for 0001622057, Nascent Biotech Inc.

  xvar xval
0 AssetsCurrent 105,414
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 776,890
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 1,457,052
11 remainder_Revenues 1,000,000
12 remainder_NetIncome -13,338
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 105,414
1 Liabilities 776,890
2 Expenses 1,457,052
3 Revenues 1,000,000
4 StockholdersEquity -671,476
5 NetIncome -470,390
6 ComprehensiveNetIncome -470,390
7 BaseVar 1,676,347
8 EconomicCapitalRatio -3.68

Edgar->Model Mapping

Feature Distribution

Change over Time